Identifying populations with faster cognitive decline using blood‐based biomarkers

Alzheimer’s & Dementia: Translational Research & Clinical Interventions · Published 2026-07-01 · DOI 10.1002/trc2.70289

Free full text

Authors (18)

James Russell Pike, Yongmei Liu, Theresa Chisolm, Jennifer Deal, Jingzhong Ding, Rebecca F. Gottesman, Alison Huang, Timothy M. Hughes, Kurt Lohman, Mason McCray, Thomas H. Mosley, Anh Tram Nguyen, Priya Palta, Nicholas Reed, Kevin J. Sullivan, Bharat Thyagarajan, Keenan A. Walker, Josef Coresh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pike, J., Liu, Y., Chisolm, T., et al. (2026). Identifying populations with faster cognitive decline using blood‐based biomarkers. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70289

Related articles

• EEG recordings during visuo‐attentive task reduce sex bias in Alzheimer's disease diagnosis · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Accelerometer‐derived daily steps, cognition, and cognitive impairment in U.S. community‐dwelling older adults: The Atherosclerosis Risk in Communities Study · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Interdaily variability of rest–activity patterns and risk of dementia in older adults: The ARIC Neurocognitive Study · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Heterogeneous responses to memantine in Alzheimer's disease: A precision medicine approach using iPSC models · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Simulation of long‐term lecanemab treatment effect on Alzheimer's disease progression · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Exploring small‐world brain connectivity in aging and its relationship with cognitive reserve · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Cerebrovascular reactivity and plasma p‐tau181 in Alzheimer's disease: Insights into APOE‐related vascular phenotypes · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal
• Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease · Alzheimer’s & Dementia: Translational Research & Clinical Interventions · 2026 · Same journal